12 completed. 12 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 12 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Migraine with Aura: new trials by email Literature Review of Migraine with Aura trials Research Report on Migraine with Aura
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine TNX-1900, Placebo Nasal Spray - Chronic Migraine, Chronic Migraine, Headache | Phase 2 | Completed | Tonix Pharmaceuticals, Inc. | 88 | 2022-12-06 | 2025-02-25 |
| Can DFN-15 Terminate Migraine With Allodynia? DFN-15, Placebo - Migraine With Aura, Migraine Without Aura | Phase 2 | Completed | Hartford Hospital | 51 | 2018-05-09 | 2019-04-16 |
| Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine Naltrexone and Acetaminophen, Naltrexone and Acetaminophen-High Dose, Naltrexone Alone (regular dose) - Migraine With or Without Aura | Phase 2 | Completed | Allodynic Therapeutics, Inc | 92 | 2017-02-18 | 2021-04-14 |
| Botox Injection in Treatment of Chronic Migraine Botulinum Toxin Type A - Migraine Disorders | Phase 1 / Phase 2 | Completed | Norwegian University of Science and Technology | 10 | 2015-02-01 | 2016-05-23 |
| Study of NXN 188 for the Treatment of Migraine With Aura NXN-188, placebo, sumatriptan succinate - Migraine With Aura | Phase 2 | Completed | NeurAxon Inc. | 239 | 2009-06-01 | 2014-08-11 |
| Candesartan Versus Propranolol for Migraine Prevention Candesartan, propranolol, placebo - Migraine Without Aura, Migraine With Aura | Phase 2 / Phase 3 | Completed | Norwegian University of Science and Technology | 72 | 2009-04-01 | 2013-12-24 |
| Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Tonabersat, Placebo - Migraine Without Aura, Migraine With Aura | Phase 2 | Completed | Minster Research Ltd | 542 | 2007-10-01 | 2009-03-31 |
| Tonabersat in the Prophylaxis of Migraine With Aura Tonabersat, Placebo - Migraine With Aura | Phase 2 | Completed | Minster Research Ltd | 39 | 2006-05-01 | 2009-08-31 |
| Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Tonabersat, Placebo - Migraine Without Aura, Migraine With Aura | Phase 2 | Completed | Minster Research Ltd | 124 | 2006-04-01 | 2009-08-31 |
| Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache Dronabinol MDI - Migraine With Aura, Migraine Without Aura | Phase 2 | Completed | Solvay Pharmaceuticals | 2005-09-01 | 2015-01-16 | |
| Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine Topiramate - Basilar Migraine | Phase 2 / Phase 3 | Completed | Monarch Medical Research | 40 | 2004-02-01 | 2012-11-12 |
| A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine Topiramate - Basilar Migraine | Phase 2 | Completed | Monarch Medical Research | 40 | 2004-02-01 | 2007-04-05 |
Migraine without Aura (7) · Migraine Disorders (5) · Headache Disorders (2) · Epilepsy (1) · Headache (1) · Hyperalgesia (1)
Brain Diseases (12) · Central Nervous System Diseases (12) · Headache Disorders, Primary (12) · Nervous System Diseases (12) · Headache Disorders (10) · Migraine Disorders (7) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Pain (1) · Sensation Disorders (1) · Somatosensory Disorders (1)
tonabersat (3) · Topiramate (2) · Acetaminophen (1) · Botulinum Toxins, Type A (1) · Celecoxib (1) · Naltrexone (1) · Propranolol (1) · Sumatriptan (1) · candesartan (1)
Minster Research Ltd (3) · Monarch Medical Research (2) · Norwegian University of Science and Technology (2) · Allodynic Therapeutics, Inc (1) · Hartford Hospital (1) · NeurAxon Inc. (1) · Solvay Pharmaceuticals (1) · Tonix Pharmaceuticals, Inc. (1)
United States (7) · Denmark (2) · Norway (2) · Hungary (1) · South Africa (1) · United Kingdom (1)
Donald W Lewis, MD (2) · Annette C Toledano, M.D. (1) · Erling A Tronvik, PhD, MD (1) · Gregory Sullivan, MD (1) · Guy Boudreau, MD (1) · Jes Olesen, MD (1) · Lars J Stovner, Ph.D. (1) · Peter Goadsby, MD (1) · Richard Lipton, MD (1)
PMID 11112243, PMID 16135345, PMID 17175134, PMID 18662331, PMID 19222510, PMID 19453963, PMID 19570717, PMID 20548058, PMID 22520687, PMID 24335848, PMID 25744676, PMID 26603732, PMID 27154997, PMID 28322750, PMID 29310498
2008 (1), 2014 (1)